Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Federal Trade Commission
Chinese Patent Office
McKinsey
Cerilliant
Medtronic
Deloitte
Healthtrust
Mallinckrodt

Generated: December 19, 2018

DrugPatentWatch Database Preview

Genentech Company Profile

« Back to Dashboard

Summary for Genentech

Drugs and US Patents for Genentech

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Genentech Inc ESBRIET pirfenidone TABLET;ORAL 208780-002 Jan 11, 2017 DISCN Yes No 8,778,947 ➤ Try a Free Trial ➤ Try a Free Trial
Genentech Inc ESBRIET pirfenidone CAPSULE;ORAL 022535-001 Oct 15, 2014 RX Yes Yes 8,383,150 ➤ Try a Free Trial Y ➤ Try a Free Trial
Genentech Inc ESBRIET pirfenidone TABLET;ORAL 208780-003 Jan 11, 2017 RX Yes Yes 7,816,383 ➤ Try a Free Trial ➤ Try a Free Trial
Genentech Inc ESBRIET pirfenidone TABLET;ORAL 208780-001 Jan 11, 2017 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial
Genentech NUTROPIN somatropin recombinant INJECTABLE;INJECTION 020168-001 Nov 17, 1993 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Genentech Inc ESBRIET pirfenidone TABLET;ORAL 208780-002 Jan 11, 2017 DISCN Yes No 8,084,475 ➤ Try a Free Trial ➤ Try a Free Trial
Genentech Inc ESBRIET pirfenidone TABLET;ORAL 208780-002 Jan 11, 2017 DISCN Yes No 7,767,700 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Genentech

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Genentech NUTROPIN DEPOT somatropin recombinant INJECTABLE;INJECTION 021075-002 Dec 22, 1999 5,656,297 ➤ Try a Free Trial
Genentech PROTROPIN somatrem INJECTABLE;INJECTION 019107-001 Oct 17, 1985 4,658,021 ➤ Try a Free Trial
Genentech NUTROPIN DEPOT somatropin recombinant INJECTABLE;INJECTION 021075-003 Dec 22, 1999 5,656,297 ➤ Try a Free Trial
Genentech NUTROPIN DEPOT somatropin recombinant INJECTABLE;INJECTION 021075-001 Dec 22, 1999 5,654,010 ➤ Try a Free Trial
Genentech NUTROPIN DEPOT somatropin recombinant INJECTABLE;INJECTION 021075-002 Dec 22, 1999 5,654,010 ➤ Try a Free Trial
Genentech NUTROPIN somatropin recombinant INJECTABLE;INJECTION 020168-001 Nov 17, 1993 5,096,885 ➤ Try a Free Trial
Genentech NUTROPIN DEPOT somatropin recombinant INJECTABLE;INJECTION 021075-003 Dec 22, 1999 5,912,015 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for GENENTECH drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Tablets 267 mg, 534 mg and 801 mg ➤ Subscribe 2018-10-15

International Patents for Genentech Drugs

Country Document Number Estimated Expiration
Cyprus 1111699 ➤ Try a Free Trial
Spain 2578715 ➤ Try a Free Trial
Croatia P20110498 ➤ Try a Free Trial
Australia 2017261491 ➤ Try a Free Trial
Australia 2014240300 ➤ Try a Free Trial
South Africa 200802237 ➤ Try a Free Trial
Poland 2324831 ➤ Try a Free Trial
Country Document Number Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for Genentech Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2013024 Lithuania ➤ Try a Free Trial PRODUCT NAME: VISMODEGIBUM; NAT. REGISTRATION NO/DATE: SWISS 62497 01 20130530; FIRST REGISTRATION: EU/1/13/848 20130712
14/002 Ireland ➤ Try a Free Trial PRODUCT NAME: ERIVEDGE-VISMODEGIB OR A SALT OR SOLVATE THEREOF; NAT REGISTRATION NO/DATE: EU/1/13/848 20130712; FIRST REGISTRATION NO/DATE: 62497 01 20130530
2016016,C1934174 Lithuania ➤ Try a Free Trial PRODUCT NAME: KOBIMETINIBAS, PASIRINKTINAI KAIP JO FARMACINIU POZIURIU PRIIMTINOS DRUSKOS IR SOLVATAI, YPAC KOBIMETINIBO HEMIFUMARATAS; REGISTRATION NO/DATE: EU/1/15/1048 20151120
00614 Netherlands ➤ Try a Free Trial PRODUCT NAME: VISMODEGIB, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT OF SOLVAAT; REGISTRATION NO/DATE: EU/1/13/848 20130712
2016 00021 Denmark ➤ Try a Free Trial PRODUCT NAME: COBIMETINIB, EVENTUELT I EN HVILKEN SOM HELST FORM BESKYTTET AF GRUNDPATENTET, DER INDBEFATTER FARMACEUTISK ACCEPTABLE SALTE OG SOLVATER, SAERLIGT COBIMETINIB HEMIFUMARAT; REG. NO/DATE: EU/1/15/1048 20151124
0160012 00193 Estonia ➤ Try a Free Trial PRODUCT NAME: KOBIMETINIIB;REG NO/DATE: EU/1/15/1048 24.11.2015
4 Finland ➤ Try a Free Trial
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
UBS
Farmers Insurance
AstraZeneca
Baxter
Fish and Richardson
Boehringer Ingelheim
Healthtrust
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.